| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 967 | 17.408 | 4.296 | 3.611 | 4.215 | 8.659 | 13.161 | 27.432 | 20.109 | 21.547 |
| Total Income - EUR | 967 | 17.430 | 4.468 | 3.611 | 4.230 | 8.659 | 13.161 | 27.443 | 20.109 | 21.547 |
| Total Expenses - EUR | 13 | 6.881 | 8.095 | 7.323 | 7.289 | 3.657 | 4.200 | 4.977 | 5.425 | 20.058 |
| Gross Profit/Loss - EUR | 954 | 10.550 | -3.627 | -3.711 | -3.059 | 5.002 | 8.961 | 22.466 | 14.684 | 1.489 |
| Net Profit/Loss - EUR | 925 | 10.027 | -3.760 | -3.820 | -3.186 | 4.757 | 8.566 | 21.643 | 12.102 | 1.274 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Labscope Research Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 126 | 13.084 | 8.784 | 4.623 | 698 | 0 | 0 | 0 | 1.621 | 1.209 |
| Current Assets | 1.053 | 12.278 | 3.298 | 2.299 | 1.802 | 4.746 | 11.115 | 27.582 | 11.210 | 12.214 |
| Inventories | 0 | 0 | 1.206 | 1.297 | 1.272 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 95 | 428 | 0 | 1.746 | 724 | 0 | 404 | 0 |
| Cash | 1.053 | 12.278 | 1.997 | 574 | 530 | 3.000 | 10.392 | 27.582 | 10.805 | 12.214 |
| Shareholders Funds | 970 | 10.987 | 7.041 | 3.092 | -153 | 4.606 | 8.615 | 21.691 | 12.151 | 1.322 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 209 | 14.375 | 5.042 | 3.829 | 2.654 | 139 | 2.501 | 5.891 | 679 | 12.100 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7211 - 7211" | |||||||||
| CAEN Financial Year |
7211
|
|||||||||
Comments - Labscope Research Srl